As we continue to learn more about the gut-brain axis, metabolic inflammation, and the overall biology that drives obesity, drugs like tirzepatide could change the landscape of diabetes treatment, obesity medicine, and chronic metabolic disease for patients around the globe
Baseline laboratory testing is required for all patients entering the program
Short Answer There is no scientific difference in absorption or weight loss efficacy between the approved injection sites
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Ian Neeland, Director, Center for Cardiovascular Prevention, Harrington Heart and Vascular Institute at University Hospitals in Cleveland and the McCamon Family Chair in Cardiovascular Excellence
The pressure to feel like herself again